Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy

NCT01927055 is registered in ClinicalTrials.gov with Chelsea Therapeutics as lead sponsor.

NCT NCT01927055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01927055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Lead sponsor
Chelsea Therapeutics
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2013
Completion date
February 28, 2015
Enrollment
61 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dopamine beta hydroxylase deficiency, multiple systems atrophy, parkinson's disease, pure autonomic failure, symptomatic neurogenic orthostatic hypotension